Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
  • C07D503/02—Preparation
  • C07D503/06—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
  • A61K31/425—Thiazoles
  • A61K31/429—Thiazoles condensed with heterocyclic ring systems
  • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
  • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
  • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
• • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
  • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
  • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
  • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
  • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

• Chemical & Material Sciences (AREA)
• Health & Medical Sciences (AREA)
• Organic Chemistry (AREA)
• Life Sciences & Earth Sciences (AREA)
• Public Health (AREA)
• Epidemiology (AREA)
• Animal Behavior & Ethology (AREA)
• General Health & Medical Sciences (AREA)
• Pharmacology & Pharmacy (AREA)
• Veterinary Medicine (AREA)
• Medicinal Chemistry (AREA)
• Molecular Biology (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
• Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
• Cephalosporin Compounds (AREA)

Priority Applications (1)

Applications Claiming Priority (4)

Publications (3)

Family

ID=26251136

Family Applications (1)

Country Status (22)

Families Citing this family (3)

• 1976
  • 1976-03-12 PT PT64897A patent/PT64897B/pt unknown
  • 1976-03-12 GR GR50291A patent/GR58256B/el unknown
  • 1976-03-18 YU YU00694/76A patent/YU69476A/xx unknown
  • 1976-03-24 AT AT215576A patent/AT342199B/de not_active IP Right Cessation
  • 1976-03-24 IL IL49279A patent/IL49279A/xx unknown
  • 1976-03-25 IE IE628/76A patent/IE42666B1/en unknown
  • 1976-03-29 ES ES446468A patent/ES446468A1/es not_active Expired
  • 1976-03-29 FR FR7609025A patent/FR2336130A1/fr active Granted
  • 1976-03-31 DK DK156576A patent/DK144066C/da not_active IP Right Cessation
  • 1976-03-31 AR AR262754A patent/AR208773A1/es active
  • 1976-04-05 MX MX000141U patent/MX3453E/es unknown
  • 1976-04-07 FI FI760946A patent/FI760946A/fi not_active Application Discontinuation
  • 1976-04-09 NO NO761241A patent/NO761241L/no unknown
  • 1976-04-12 LU LU74749A patent/LU74749A1/xx unknown
  • 1976-04-12 SE SE7604287A patent/SE427037B/xx unknown
  • 1976-04-12 NL NL7603840A patent/NL7603840A/xx not_active Application Discontinuation
  • 1976-04-13 JP JP51042313A patent/JPS51127093A/ja active Pending
  • 1976-04-13 DE DE19762616088 patent/DE2616088A1/de not_active Withdrawn
  • 1976-04-13 CH CH470276A patent/CH602742A5/xx not_active IP Right Cessation
  • 1976-04-13 CA CA250,165A patent/CA1074802A/en not_active Expired
  • 1976-04-14 HU HU76BE1258A patent/HU175444B/hu unknown
  • 1976-04-14 AU AU13020/76A patent/AU497577B2/en not_active Expired

Also Published As

Similar Documents

Legal Events